BIOLIFE SOLUTIONS INC
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 2. PROPERTIES
Our material office and manufacturing leases are detailed below:
| Location | Square Feet | Principal Use | Lease Expiration |
|---|---|---|---|
| Bothell, WA | 75,241 | Corporate headquarters, manufacturing, research and development, marketing, and administrative offices | July 2031 |
| Woodinville, WA | 13,578 | Warehouse | February 2030 |
| Manchester, CT | 524 | Research and development | August 2026 |
| Indianapolis, IN | 10,890 | Manufacturing, research and development, and administrative offices | June 2027 |
| Edmonton, AB | 200 | Research and development | March 2026 |
| Ottawa, ON | 200 | Research and development | December 2026 |
We consider the facilities to be in a condition suitable for their current uses. Due to the increasing requirements of customers or regulatory agencies, we may need to acquire additional space or upgrade and enhance existing space. We believe that adequate facilities will be available upon the conclusion of our leases.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.